Drug Shortage Report for LANSOPRAZOLE

Last updated on 2018-09-19 History
Report ID 37275
Drug Identification Number 02433001
Brand name LANSOPRAZOLE
Common or Proper name LANSOPRAZOLE
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 15MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-24
Estimated end date
Actual end date 2018-09-18
Shortage status Resolved
Updated date 2018-09-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2018-09-19 French Compare
v11 2018-09-19 English Compare
v10 2018-08-24 French Compare
v9 2018-08-24 English Compare
v8 2018-07-13 French Compare
v7 2018-07-13 English Compare
v6 2018-06-06 French Compare
v5 2018-06-06 English Compare
v4 2018-04-19 French Compare
v3 2018-04-19 English Compare
v2 2018-01-26 French Compare
v1 2018-01-26 English Compare

Showing 1 to 12 of 12